Heritable variation of ERBB2 and breast cancer risk

Cancer Epidemiology Biomarkers and Prevention

Volumn 18, Issue 4, 2009, Pages 1252-1258

  Breyer, Joan P ^a   Sanders, Melinda E ^a   Airey, David C ^a   Cai, Qiuyin ^a   Yaspan, Brian L ^a   Schuyler, Peggy A ^a   Dai, Qi ^a   Boulos, Fouad ^a,c   Olivares, Maria G ^a   Bradley, Kevin M ^a   Gao, Yu Tang ^d   Page, David L ^a   Dupont, William D ^a   Zheng, Wei ^a,e   Smith, Jeffrey R ^a,b,e  

^a VANDERBILT INGRAM CANCER CENTER   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

^d SHANGHAI CANCER INSTITUTE   (China)

^e VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2;

ADULT; ALLELE; ARTICLE; BREAST CANCER; CANCER GRADING; CANCER INVASION; CANCER RISK; CANCER STAGING; CANCER SUSCEPTIBILITY; CHINESE; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; GENE LINKAGE DISEQUILIBRIUM; GENE LOCATION; GENE LOCUS; GENETIC MODEL; GENETIC VARIABILITY; GENOTYPE; GERM LINE; HAPLOTYPE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MISSENSE MUTATION; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM; TANDEM REPEAT;

ADENOCARCINOMA; ADULT; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, LOBULAR; CASE-CONTROL STUDIES; CHINA; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; LINKAGE DISEQUILIBRIUM; MIDDLE AGED; MUTATION, MISSENSE; POLYMORPHISM, SINGLE NUCLEOTIDE; PROGNOSIS; RECEPTOR, ERBB-2; RISK FACTORS; TANDEM REPEAT SEQUENCES;

EID: 66649133396     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-08-1202     Document Type: Article

References (35)

1. Abd El-Rehim DM, Pinder SE, Paish CE, et al. Expression and coexpression of the members of the epidermal growth factor receptor (EGFR) family in invasive breast carcinoma. Br J Cancer 2004;91:1532-1542 (Pubitemid 39486359)
2. Kirschbaum MH, Yarden Y. The ErbB/HER family of receptor tyrosine kinases: a potential target for chemoprevention of epithelial neoplasms. J Cell Biochem 2000;77:52-60. (Pubitemid 30176733)
3. Ross JS, Fletcher JA, Linette GP, et al. The Her-2/neu gene and protein in breast cancer 2003: biomarker and target of therapy. Oncologist 2003;8:307-325
4. Bilous M, Ades C, Armes J, et al. Predicting the HER2 status of breast cancer from basic histopathology data: an analysis of 1500 breast cancers as part of the HER2000 International Study. Breast 2003;12:92-98 (Pubitemid 36553037)
5. Hoff ER, Tubbs RR, Myles JL, Procop GW. HER2/neu amplification in breast cancer: stratification by tumor type and grade. Am J Clin Pathol 2002;117:916-921 (Pubitemid 34564348)
6. Janocko LE, Brown KA, Smith CA, et al. Distinctive patterns of Her-2/neu, c-myc, and cyclin D1 gene amplification by fluorescence in situ hybridization in primary human breast cancers. Cytometry 2001;46:136-149 (Pubitemid 32643095)
7. Kommoss F, Colley M, Hart CE, Franklin WA. In situ distribution of oncogene products and growth factor receptors in breast carcinoma: c-erbB-2 oncoprotein, EGFr, and PDGFr-h-subunit. Mol Cell Probes 1990;4:11-23.
8. Ramachandra S, Machin L, Ashley S, Monaghan P, Gusterson BA. Immunohistochemical distribution of c-erbB-2 in in situ breast carcinoma - a detailed morphological analysis. J Pathol 1990;161:7-14. (Pubitemid 20173376)
9. Sastre-Garau X, Jouve M, Asselain B, et al. Infiltrating lobular carcinoma of the breast. Clinicopathologic analysis of 975 cases with reference to data on conservative therapy and metastatic patterns. Cancer 1996;77:113-120
10. Benusiglio PR, Lesueur F, Luccarini C, et al. Common ERBB2 polymorphisms and risk of breast cancer in a white British population: a case-control study. Breast Cancer Res 2005;7:R204-9.
11. Benusiglio PR, Pharoah PD, Smith PL, et al. HapMap-based study of the 17q21 ERBB2 amplicon in susceptibility to breast cancer. Br J Cancer 2006;95:1689-1695 (Pubitemid 44950795)
12. Han W, Kang D, Lee JE, et al. A haplotype analysis of HER-2 gene polymorphisms: association with breast cancer risk, HER-2 protein expression in the tumor, and disease recurrence in Korea. Clin Cancer Res 2005;11:4775-4778
13. Frazer KA, Ballinger DG, Cox DR, et al. A second generation human haplotype map of over 3.1 million SNPs. Nature 2007;449:851-861 (Pubitemid 47598626)
14. Hunter DJ, Kraft P, Jacobs KB, et al. A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer. Nat Genet 2007;39:870-874 (Pubitemid 47014500)
15. Casalini P, Iorio MV, Galmozzi E, Menard S. Role of HER receptors family in development and differentiation. J Cell Physiol 2004;200:343-350 (Pubitemid 39006925)
16. Stern DF. ErbBs in mammary development. Exp Cell Res 2003;284:89-98. (Pubitemid 36331968)
17. Troyer KL, Lee DC. Regulation of mouse mammary gland development and tumorigenesis by the ERBB signaling network. J Mammary Gland Biol Neoplasia 2001;6:7-21. (Pubitemid 33640643)
18. Gao YT, Shu XO, Dai Q, et al. Association of menstrual and reproductive factors with breast cancer risk: results from the Shanghai Breast Cancer Study. Int J Cancer 2000;87:295-300. (Pubitemid 30434361)
19. Zheng W, Gao YT, Shu XO, et al. Population-based case-control study of CYP11A gene polymorphism and breast cancer risk. Cancer Epidemiol Biomarkers Prev 2004;13:709-714 (Pubitemid 38737857)
20. Elston CW, Ellis IO. Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology 1991;19:403-410
21. Harris JR. Diseases of the breast. 3rd ed. Philadelphia: Lippincott Williams & Wilkins; 2004.
22. Page DL. Special types of invasive breast cancer, with clinical implications. Am J Surg Pathol 2003;27:832-835 (Pubitemid 36617522)
23. Page DL, Anderson TJ. Diagnostic histopathology of the breast. Edinburgh: Churchill Livingstone; 1987.
24. Singletary SE, Allred C, Ashley P, et al. Revision of the American Joint Committee on Cancer staging system for breast cancer. J Clin Oncol 2002;20:3628-3636 (Pubitemid 34983222)
25. Chen X, Levine L, Kwok PY. Fluorescence polarization in homogeneous nucleic acid analysis. Genome Res 1999;9:492-498 (Pubitemid 29267681)
26. Brownstein MJ, Carpten JD, Smith JR. Modulation of nontemplated nucleotide addition by Taq DNA polymerase: primer modifications that facilitate genotyping. Biotechniques 1996;20:1004-6, 1008-1010 (Pubitemid 26194853)
27. Barrett JC, Fry B, Maller J, Daly MJ. Haploview: analysis and visualization of linkage disequilibrium and haplotype maps. Bioinformatics 2005;21:263-265 (Pubitemid 40202029)
28. Gaunt TR, Rodriguez S, Zapata C, Day IN. MIDAS: software for analysis and visualisation of interallelic disequilibrium between multiallelic markers. BMC Bioinformatics 2006;7:227. (Pubitemid 43885035)
29. Marchini J, Cutler D, Patterson N, et al. A comparison of phasing algorithms for trios and unrelated individuals. Am J Hum Genet 2006;78:437-450 (Pubitemid 43291226)
30. Stephens M, Donnelly P. A comparison of Bayesian methods for haplotype reconstruction from population genotype data. Am J Hum Genet 2003;73:1162-1169 (Pubitemid 37414228)
31. Stephens M, Smith NJ, Donnelly P. A new statistical method for haplotype reconstruction from population data. Am J Hum Genet 2001;68:978-989 (Pubitemid 32289743)
32. Cristofanilli M, Gonzalez-Angulo A, Sneige N, et al. Invasive lobular carcinoma classic type: response to primary chemotherapy and survival outcomes. J Clin Oncol 2005;23:41-48 (Pubitemid 41702621)
33. Xie D, Shu XO, Deng Z, et al. Population-based, case-control study of HER2 genetic polymorphism and breast cancer risk. J Natl Cancer Inst 2000;92:412-417 (Pubitemid 30154823)
34. Frank B, Hemminki K, Burwinkel B. A bias in genotyping the ERBB2 (HER2) Ile655Val variant. Carcinogenesis 2005;26:1649. (Pubitemid 41236059)
35. Yaspan BL, Breyer JP, Cai Q, et al. Haplotype analysis of CYP11A1 identifies promoter variants associated with breast cancer risk. Cancer Res 2007;67:5673-5682 (Pubitemid 46984999)